Supporting Investigator Initiated Trials
Investigator-initiated Trials (IITs) are conducted under the full responsibility of a third-party such as an academic institution, research universities, hospitals, or by individual qualified investigators with or without the assistance of a pharmaceutical sponsor.
Carefully planned and executed IIT strategies provide quick proof-of-concept data and accelerate drug and device development. IITs provide expanded product knowledge regarding safety and efficacy. New ways of using approved therapeutic products are often identified by physicians, resulting in improved treatment outcomes for patients.
With over 15+ years experience, our CRO team can provide end-to-end support for Principal Investigators and other independent research organizations to successfully conduct clinical trials and generate scientific evidence.